Kamal Ramzipoor

Biography

Mr. Ramzipoor is the president and chief executive officer of Amaranth Medical, Inc. He oversees all aspects of the company’s operations, including research and development, global manufacturing operations, regulatory, clinical and finance. Kamal has spent more than 28 years developing products and technologies for the medical device industry. Prior to co-founding Amaranth, he served as the director of the ischemic stroke franchise for the Neurovascular Division of Boston Scientific Corporation (BSC), where he was responsible for developing and managing a portfolio of “best in class” intravascular devices for the treatment of stroke. Before joining BSC, he was chief technology officer and vice president of research and development at Micrus Endovascular Corporation (acquired by Johnson & Johnson). Mr. Ramzipoor’s previous positions include senior director of research and development at Acuson Corporation (acquired by Siemens) and director of research and development at Progressive Angioplasty Systems (acquired by US Surgical). Earlier in his career, Mr. Ramzipoor held various engineering and management positions at Guidant and BSC. Prior to entering the medical device field, he spent several years in the aerospace industry, developing polymer-based, high-strength composites for a variety of applications. Mr. Ramzipoor received his BS in Mechanical Engineering from the Detroit Institute of Technology and is an inventor and author on more than 100 US patents and publications.

Research Interest

cardiology